PAS
Point72 Asia (Singapore) Portfolio holdings
AUM
$563M
1-Year Return
23.62%
This Quarter Return
-3.6%
1 Year Return
+23.62%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$381M
AUM Growth
+$2.35M
(+0.62%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
24.21%
Holding
1,277
New
435
Increased
204
Reduced
183
Closed
443
Top Buys
| 1 |
Credo Technology Group
CRDO
|
+$13.9M |
| 2 |
Kellanova
K
|
+$13.3M |
| 3 |
Blackrock
BLK
|
+$12M |
| 4 |
Tapestry
TPR
|
+$7.13M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$6.43M |
Top Sells
| 1 |
TSMC
TSM
|
+$26.9M |
| 2 |
Salesforce
CRM
|
+$14M |
| 3 |
Netflix
NFLX
|
+$11.7M |
| 4 |
Amphenol
APH
|
+$9.77M |
| 5 |
Broadcom
AVGO
|
+$5.97M |
Sector Composition
| 1 | Technology | 21.31% |
| 2 | Financials | 19.94% |
| 3 | Industrials | 11.18% |
| 4 | Healthcare | 10.51% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
eHealth
EHTH
$115M
| $151K | 0.04% |
22,539
-12,696
| -36% | -$84.8K |
|
327
Cavco Industries
CVCO
$4.28B
| $150K | 0.04% |
+290
| New | +$150K |
|
328
Xeris Biopharma Holdings
XERS
$1.26B
| $150K | 0.04% |
+27,268
| New | +$150K |
|
329
Herc Holdings
HRI
$4.43B
| $148K | 0.04% |
1,103
+789
| +251% | +$106K |
|
330
CSG Systems International
CSGS
$1.82B
| $147K | 0.04% |
2,433
+1,254
| +106% | +$75.8K |
|
331
Integer Holdings
ITGR
$3.59B
| $146K | 0.04% |
+1,238
| New | +$146K |
|
332
Elevance Health
ELV
$69.1B
| $146K | 0.04% |
+336
| New | +$146K |
|
333
Levi Strauss
LEVI
$8.59B
| $143K | 0.04% |
9,194
+7,217
| +365% | +$113K |
|
|
RDFN
334
DELISTED
Redfin
RDFN
| $143K | 0.04% |
15,482
+12,065
| +353% | +$111K |
|
335
Envista
NVST
$3.45B
| $142K | 0.04% |
+8,228
| New | +$142K |
|
336
Payoneer
PAYO
$2.33B
| $141K | 0.04% |
+19,352
| New | +$141K |
|
337
DraftKings
DKNG
$22.7B
| $141K | 0.04% |
4,231
+3,468
| +455% | +$115K |
|
338
Eton Pharmaceutcials
ETON
$467M
| $140K | 0.04% |
10,795
+234
| +2% | +$3.04K |
|
339
Hain Celestial
HAIN
$176M
| $140K | 0.04% |
+33,693
| New | +$140K |
|
340
The Bancorp
TBBK
$3.5B
| $139K | 0.04% |
+2,628
| New | +$139K |
|
341
Calix
CALX
$4.11B
| $139K | 0.04% |
+3,916
| New | +$139K |
|
342
Protalix BioTherapeutics
PLX
$135M
| $139K | 0.04% |
54,174
+667
| +1% | +$1.71K |
|
343
Apogee Enterprises
APOG
$896M
| $139K | 0.04% |
2,989
+1,763
| +144% | +$81.7K |
|
344
DexCom
DXCM
$29.8B
| $138K | 0.04% |
2,018
-21,671
| -91% | -$1.48M |
|
345
Y-mAbs Therapeutics
YMAB
$390M
| $138K | 0.04% |
+31,088
| New | +$138K |
|
346
Expensify
EXFY
$174M
| $137K | 0.04% |
45,131
-23,148
| -34% | -$70.4K |
|
347
Rush Enterprises Class B
RUSHB
$4.4B
| $135K | 0.04% |
+2,397
| New | +$135K |
|
348
Deckers Outdoor
DECK
$16.9B
| $135K | 0.04% |
1,203
+1,022
| +565% | +$114K |
|
349
Buckle
BKE
$3.06B
| $134K | 0.04% |
+3,495
| New | +$134K |
|
350
Cardinal Health
CAH
$35.6B
| $134K | 0.04% |
+970
| New | +$134K |
|